Status
Conditions
Treatments
About
Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in perimenopausal women and the same thickness does not express the same endometrial volume in different endometrium because uterine lengths may be different and endometrial irregularities may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no study assess endometrial volume measured by two dimension TVS in prediction of endometrial pathology, however it is cheap and available than 3D TVS.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
*perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and polymenorrhea.
Exclusion criteria
*general or local causes of bleeding, drug intake or recent hormonal contraception
Primary purpose
Allocation
Interventional model
Masking
100 participants in 1 patient group
Loading...
Central trial contact
Waleed Elrefaie, MD; Hanan Nabil, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal